T2 Biosystems Inc. (TTOO): Billionaire Julian Robertson’s Tiger Management Significantly Increases Its Stake

Page 8 of 12

Page 8 of 12 – SEC Filing
CUSIP No
89853L104
Item 1.
(a).
Name of Issuer:
T2 Biosystems, Inc.
(b).
Address of Issuer’s Principal Executive Offices:
101 Hartwell Avenue
Lexington, MA 02421
Item 2.
(a).
Name of Person Filing:
Tiger Partners Trading LLC
Tiger Partners, L.P.
Tiger Partners GP, L.L.C.
Tiger Management L.L.C.
The Julian H. Robertson, Jr. Revocable Trust
Julian H. Robertson, Jr.
(b).
Address of Principal Business Office, or if None, Residence:
101 Park Avenue
New York, NY 10178
(c).
Citizenship:
Tiger Partners Trading LLC – Delaware
Tiger Partners, L.P. – Delaware
Tiger Partners GP, L.L.C. – Delaware
Tiger Management L.L.C. – Delaware
The Julian H. Robertson, Jr. Revocable Trust – Delaware
Julian H. Robertson, Jr. – United States of America
(d).
Title of Class of Securities:
Common Stock, $0.001 par value
(e).
CUSIP Number:
89853L104
Item 3.
If This Statement is filed pursuant to ss.240.13d-1(b) or 240.13d-2(b), or (c), check whether the person filing is a
(a)
[_]
Broker or dealer registered under Section 15 of the Exchange Act (15 U.S.C. 78c).
(b)
[_]
Bank as defined in Section 3(a)(6) of the Exchange Act (15 U.S.C. 78c).
(c)
[_]
Insurance company as defined in Section 3(a)(19) of the Exchange Act (15 U.S.C. 78c).
(d)
[_]
Investment company registered under Section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8).
(e)
[_]
An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)
[_]
An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)
[_]
A parent holding company or control person in accordance with Rule 13d-1(b)(1)(ii)(G);
(h)
[_]
A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C.1813);
(i)
[_]
A church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)
[_]
Group, in accordance with s.240.13d-1(b)(1)(ii)(J).

Follow T2 Biosystems Inc. (NASDAQ:TTOO)

Page 8 of 12